Forum

, Volume 33, Issue 3, pp 162–164 | Cite as

Unkontrollierte komplementäre Medizin verzerrt Studienergebnisse – Pro und Kontra

Oxford-Debatte
  • Christoph A. Ritter
  • die Arbeitsgemeinschaft Onkologische Pharmazie (OPH)
  • André-Michael Beer
  • die Arbeitsgemeinschaft Prävention und Integrative Onkologie (PRiO)
Meinung
  • 17 Downloads

Uncontrolled complementary medicine distorts clinical trial results – pros and cons

An Oxford debate

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

C.A. Ritter und A.-M. Beer geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Literatur

  1. 1.
    European Medicines Agency Guideline on the evaluation of anticancer medicinal products in man, Appendix 2: The use of patient-reported outcome (PRO) measures in oncology studies. EMA/CHMP/292464/2014, 1. April 2016Google Scholar
  2. 2.
    Domnick M, Domnick M, Wiebelitz KR, Beer AM (2017) Evaluation of the effectiveness of a multimodal complementary medicine program for improving the quality of life of cancer patients during adjuvant radiotherapy and/or chemotherapy or outpatient aftercare. Oncology 93(2):83–91CrossRefPubMedGoogle Scholar
  3. 3.
    Thill M, Liedtke C, Solomayer E‑F, Müller V, Janni W, Schmidt M, AGO Breast Committee (2017) AGO recommendations for the diagnosis and treatment of patients with advanced and metastatic breast cancer: update 2017. Breast Care (Basel) 12:184–191CrossRefGoogle Scholar
  4. 4.
    Shalom-Sharabi I, Lavie O, Samuels N, Keinan-Boker L, Lev E, Ben-Arye E (2017) Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting. J Cancer Res Clin Oncol 143(12):2535–2543CrossRefPubMedGoogle Scholar
  5. 5.
    Ernst E, Schmidt K, Steuer-Vogt MK (2003) Mistletoe for cancer? A systematic review of randomised clinical trials. Int J Cancer 107(2):262–267CrossRefPubMedGoogle Scholar
  6. 6.
    Horneber MA, Bueschel G, Huber R, Linde K, Rostock M (2008) Mistletoe therapy in oncology. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.cd003297.pub2 PubMedGoogle Scholar
  7. 7.
    Melzer J, Iten F, Hostanska K, Saller R (2009) Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review. Forsch Komplementmed 16(4):217–226PubMedGoogle Scholar
  8. 8.
    Jacob SA, Khan TM, Lee LH (2017) The effect of green tea consumption on prostate cancer risk and progression: a systematic review. Nutr Cancer 69(3):353–364CrossRefPubMedGoogle Scholar
  9. 9.
    Pittler MH, Ernst E (2007) Clinical effectiveness of garlic (allium sativum). Mol Nutr Food Res 51(11):1382–1385CrossRefPubMedGoogle Scholar
  10. 10.
    van Die MD, Bone KM, Williams SG, Pirotta MV (2014) Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int 113(5b):E119–E130CrossRefPubMedGoogle Scholar
  11. 11.
    Yang J, Zhu L, Wu Z, Wang Y (2013) Chinese herbal medicines for induction of remission in advanced or late gastric cancer. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.cd005096.pub4 Google Scholar
  12. 12.
    Chen X, Deng L, Jiang X, Wu T (2016) Chinese herbal medicine for oesophageal cancer. Cochrane Database Syst Rev.  https://doi.org/10.1002/14651858.cd004520.pub7 PubMedCentralGoogle Scholar
  13. 13.
    Ziemann J, Ritter CA (2017) Onkologische Medikamente und Phytotherapeutika – Gibt es Wechselwirkungen? J Onkol 10:845–850Google Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • Christoph A. Ritter
    • 1
  • die Arbeitsgemeinschaft Onkologische Pharmazie (OPH)
  • André-Michael Beer
    • 2
  • die Arbeitsgemeinschaft Prävention und Integrative Onkologie (PRiO)
  1. 1.Institut für Pharmazie – Klinische PharmazieErnst-Moritz-Arndt Universität GreifswaldGreifswaldDeutschland
  2. 2.Klinik Blankenstein, Lehrbereich NaturheilkundeRuhr-Universität BochumHattingenDeutschland

Personalised recommendations